Miguel R. Ossandon, Ph.D.

Miguel R. Ossandon has a dual background in clinical laboratory and computer science. He started working in cancer research at the Lombardi Cancer Center at Georgetown University where he also began his undergraduate training in computer science. He is working for the National Cancer Institute since 2007.

Miguel received his master’s degree at The George Washington University and Ph.D. in computer science at the University of Maryland Baltimore County.

As a Program Director in the Diagnostic Biomarkers and Technology Branch, he manages a grant portfolio related to computational modeling and machine learning approaches for cancer diagnosis, digital image processing/analysis, microfluidic and circulating tumor cell technology.

Selected Publications

• Rid A, Aguilera B, Banda C, et al. Global health reciprocal innovation: ethical, legal and regulatory considerations. BMJ Glob Health. 2024;8(Suppl 7):e014693. Published 2024 May 30. doi:10.1136/bmjgh-2023-014693
• Ossandon MR, Sorg BS, Phatak DS, Kalpakis K. Evaluation of Tumor Development Using Hemoglobin Saturation Profile on Rodent Dorsal Window Chamber. Methods Mol Biol. 2022;2393:179-206. doi:10.1007/978-1-0716-1803-5_10
• Ossandon MR, Agrawal L, Bernhard EJ, et al. Circulating Tumor DNA Assays in Clinical Cancer Research. J Natl Cancer Inst. 2018;110(9):929-934. doi:10.1093/jnci/djy105
• Haney K, Tandon P, Divi R, Ossandon MR, Baker H, Pearlman PC. The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary. IEEE J Transl Eng Health Med. 2017;5:2800514. Published 2017 Nov 23. doi:10.1109/JTEHM.2017.2761764
• Biomedical Engineering Technologies Volume 1. Miguel R. Ossandon, Houston Baker, Avraham Rasooly. Springer Nature 2022